Annals Internal Medicine, Author Interviews, Pulmonary Disease / 13.03.2017
Cystic Fibrosis Patients Survive Ten Years Longer in Canada than in US
MedicalResearch.com Interview with:
Dr. Anne L. Stephenson, MD, PhD
St. Michael’s Hospital
Toronto Canada
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Both Canada and the US have maintained national registries on individuals with cystic fibrosis (CF) dating back to the 1970s. Previous reports suggested that survival differed between the two countries however direct comparisons of survival estimates between national registry reports were limited because of differences in methodologies used, data processing techniques and possible differences in the patients captured within each registry.
We aimed to compare survival in cystic fibrosis between Canada and the US to determine if differences existed when we applied a systematic and standardized approach.
Our analysis showed that between 1990 and 2013, survival for individuals with CF increased in both countries, however, the rate of increase was faster in Canada compared to the USA. The survival gap widened at two distinct time points: 1995 and 2005.
In the contemporary period between 2009 and 2013, the median age of survival for individuals with cystic fibrosis in Canada was found to be 50.9 years compared to 40.6 years in the US. Overall, the risk of death was 34% lower for Canadians compared Americans with CF after adjusting for markers of disease severity. When US CF subjects were classified by insurance status, we found a 77% lower risk of death among Canadians with CF compared to Americans who indicated unknown or no insurance, a 44% lower risk compared to Americans receiving continuous Medicare/Medicaid, and a 36% lower risk in Canadians compared to Americans receiving intermittent Medicare/Medicaid. The risk of death for Americans with private insurance was not statistically different from that of Canadians with cystic fibrosis .
(more…)